Nanocarry Therapeutics Israeli Company

Nanocarry is developing therapeutics based on bioengineered nanoparticles with novel capabilities to treat oncology indications and brain diseases. The company’s AxS platform can be easily modified to deliver a wide array of biologics, safely and effectively, to the brain and beyond.